统计信号检测中的风险因素考量:利用亚组不成比例分析发现VigiBase中药物不良反应的风险群体
对354个优先统计信号评估后,共传播7个信号,描述年龄(老年人)、性别(男性和女性)、BMI(体重不足和肥胖)和地理区域(亚洲)相关的先前未识别的潜在风险群体,除一个外均针对已确立的不良反应。
要点
- 亚组不成比例分析可发现全库未显现的风险群体信号。
- 共评估354个优先信号,传播7个风险群体信号。
- 信号涉及年龄、性别、BMI和地理区域风险因素。
核心结论
- 将广泛风险因素筛查纳入全球不良事件报告数据库的统计信号检测,可以发现药物不良反应的风险群体信号。
主要发现
- 对354个优先统计信号进行评估,传播了7个描述先前未识别潜在风险群体的信号。
- 传播信号涉及年龄(老年人)、性别(男性和女性)、BMI(体重不足和肥胖)和地理区域(亚洲),除一个外均针对已确立的不良反应。
临床怎么用
- 在临床药学信号检测中可考虑按风险因素亚组开展不成比例分析,以识别特定人群的用药风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In the treatment of the individual patient, a vision is to achieve the best possible balance between benefit and harm. Such tailored therapy relies upon the identification and characterisation of risk factors for adverse drug reactions. Information relevant to risk factor considerations can be captured in adverse event reports and could be utilised in statistical signal detection. OBJECTIVE: The aim of this study was to explore whether statistical screening of a broad range of risk factors within a global database of adverse event reports could uncover signals of risk groups for adverse drug reactions. METHODS: Subgroup disproportionality analysis was applied to 15.4 million reports entered in VigiBase, the World Health Organization (WHO) global database of individual case safety reports, up to August 2017. Disproportionality analyses for drug-adverse event pairs were performed (1) in the full database and (2) across a range of subgroups defined by the following covariates: patient age, sex, body mass index, pregnancy, underlying condition, reporting country, and geographical region. Drug-adverse event pairs disproportionately over-reported in such subgroups, but not in the full database, and with a substantial difference between the two observed-to-expected ratios, were highlighted as statistical signals. These were further prioritised, through filtering and sorting, for clinical assessment, whereafter clinically relevant signals were communicated to the pharmacovigilance community and the public. RESULTS: Assessments were performed for 354 prioritised statistical signals, resulting in seven communicated signals describing previously unrecognised potential risk groups related to age (elderly), sex (male and female), body mass index (underweight and obese), and geographical region (Asia), all except one for already established adverse drug reactions. Important aspects considered in the assessments included an evaluation of the disproportionate over-reporting in the subgroup by reviewing alternative explanations and reporting patterns for similar drugs/adverse events/subgroups, and a search for plausible mechanisms to support the risk hypothesis. CONCLUSIONS: This study reveals that it is possible to uncover signals of risk groups for adverse drug reactions through incorporation of broad risk factor screening into statistical signal detection in a global database of adverse event reports. Our findings suggest the potential to use such statistical methodologies for risk characterisation in subpopulations of concern.
引用
- Sandberg L, Taavola H, Aoki Y, et al. Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase. Drug Saf. 2020. PMID: 32564242. doi:10.1007/s40264-020-00957-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。